Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
O

Open Orphan PLC
LSE:ORPH

Watchlist Manager
Open Orphan PLC
LSE:ORPH
Watchlist
Price: 10 GBX 5.26% Market Closed
Market Cap: £67.1m
Write Note Create Alert Ask AI

Open Orphan PLC
Investor Relations

Open Orphan Plc provides pharmaceutical development services. The firm is engaged in the testing of vaccines and antivirals using human clinical trials. The firm has a presence in the United Kingdom, Ireland, France and Netherlands. The Company, through its subsidiary hVIVO Limited, is also engaged in the data platform business. hVIVO Limited has built up databases of infectious disease progression data and the Company is populating its Open Orphan Health Data platform with hVIVO data. The firm also operates through its subsidiary Venn Life Sciences, which is an integrated drug development partner. Venn Life Sciences offers a combination of drug development consultancy, clinical trial design and execution to create, plan and execute drug development programs for its customers.

Show more
Loading
ORPH
FTSE All Share Index
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Yamin Mohammed Khan Ph.D.
CEO & Director
No Bio Available
Mr. Stephen Pinkerton
CFO & Exec. Director
No Bio Available
John Sheridan
Chief Operating Officer
No Bio Available
Mr. Andrew Catchpole
Chief Scientific Officer
No Bio Available
Dr. Maurice N. Treacy Ph.D.
Chief Commercial Officer
No Bio Available
Mr. Leo Toole
Exec. Officer
No Bio Available

Contacts

Address
London
Queen Mary BioEnterprises, Innovation Centre, 42 New Road,
Contacts
+442890737900.0
www.vennlifesciences.com
sparklesyt

See Also

Summary
ORPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
ORPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ORPH stock valuation using valuation multiples.
Wall Street Estimates
ORPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ORPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 315,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.